89.

Faria A. V., de Macedo F. C. Jr, Ferreira M. M. C., Marsaioli A J., Cendes F., "In vitro biochemical classification of brain tumors by high field 1H MRS". Águas de Lindóia, SP, Brazil, 10-15/09/2006: 10th International Conference on Chemometrics in Analytical Chemistry (CAC-2006, CAC-X), Book of Abstracts (2006) P070. Poster 070.


10th International Conference on Chemometrics in Analytical Chemistry P070

In vitro biochemical classification of brain tumors by high field 1H
MRS

Andréia Vasconcellos1*, Fernando César de Macedo Júnior3, Márcia M. C. Ferreira3,
Anita Jocelyne Marsaioli3, Fernando Cendes2

1Department of Radiology and 2Neurology, Faculty of Medical Sciences, State University of Campinas
(UNICAMP), Campinas, SP, Brazil
3Chemistry Institute, State University of Campinas (UNICAMP), Campinas, SP, Brazil
 

______________________________________________________________________________________
 

     Hydrogen  magnetic  resonance spectroscopy  (1H NMR)  performed  at  low  fields  is  a  non-invasive
method and a useful tool for the diagnosis of tumors in vivo.   High field 1H MRS,  on the other hand,  has
been used to study biochemical changes in distinct pathologies in vitro based on the pattern of metabolite
distribution  in  tissue extracts.   It is also useful  for  identifying  the  distinct metabolic profiles  of  specific
histological subtypes of brain tumors,  aiming  for the optimization  of  the in  vivo  1H NMR  spectroscopy
protocols.  The accurate analysis and classification of different spectra, however,  remains a challenge. In
this work,  brain tissue samples from patients  with  various types  of  brain tumors were analyzed by  high
field (B0 = 11.7 T) 1H MRS in the region 1.22 - 4.25 ppm. Spectra were corrected to phase shift,  baseline
corrected using  a  linear fit and point wise scaled  by  the  sum of  all intensities  (normalized to unit area).
     Partial Least Square Discriminant Analysis (PLS-DA) on autoscaled  data revealed a tendency of high-
grade neuroglial tumors  in  increasing  glycine   and  glutamine/glutamate  and   decreasing  myo-inositol.
Creatine  and  NAA  were  clearly decreased  in  non-neuroglial tumors  and  alanine  was higher  in  non-
neuroglial   tumor  followed   by   high-grade  neuroglial  tumors.   Choline  compounds  had  a   particular
distribution in metastasis and  non-neuroglial tumors with increasing of GPC peak and decreasing  of  PC
peak when compared with neuroglial tumors and control.  None or at most one sample was  misclassified
during the leave-one-out crossvalidation procedure.   These results allowed brain tumors  to  be grouped
according  to  their  specific  histological  subtypes  and  degree   of  agressiveness,  reflecting  particular
characteristics of tumor original cell and neoplastic cells' metabolic abnormalities possibly related  to high
turnover, resistance to apoptosis, osmotic stress and their tendency to aerobic glycolysis.

Acknowledgment. FAPESP, CNPq.
______________________________________________________________________________________